Since the foundation of emovis in 2001, Dr. Bettina Bergtholdt, MD has been the head of emovis in the capacity of Executive Manager (CEO). Now she has handed over the operational management of the site to Ute Bertelsmann in order to devote herself to strategic corporate development. Ms. Bertelsmann is supported by the administration, a growing team of secretaries, accounting, quality management and marketing. In the study center - one floor up - the investigators, the study nurses, the laboratory nurses and study coordinators as well as the patient telephone and the reception are hard at work.
Dr. Bettina Bergtholdt, MD is well known in Germany’s Clinical Research field. She has led emovis in the capacity of Executive Manger (CEO) since 2001. In that time, she has successfully led the emovis study team in over 150 clinical trials. In 2012, she founded the Home Care Visits business unit and, in 2014, together with Carolin Kurth, Camovis GmbH.
In February 2019, Dr. med. Bergtholdt consigned the operational management of emovis GmbH. Dr. Bergtholdt is now dedicated to the strategic development of emovis GmbH. This includes the expansion of existing business units and the development of new services in the area of clinical research.
Ninon Werner holds the leading position of the study site. Her work combines the different fields of projects, clients and partners. Her responsibilities lie in the fulfilment of high standards and the frictionless procedure of projects.
Mahak Aneja has been a team member of emovis since June 2020. As Business Development Manager she is your contact partner for the following subjects:
Renée Werner is responsible for recruiting patients at emovis. She generates and navigates the campaigns for our different clinical trials. Frau Werner is your contact partner for the segments:
Mark Kuhrt has been Dr. Bergtholdt’s secretary for many years. He is your contact partner for the following subjects:
Since January 2018 Wenke Schulte is responsible for the quality management within emovis. This includes the writing, scrutinizing and adherence of the SOPs, the implementing intern Audits, CAPAs and the attendance of extern Audits.
The investigators are primarily responsible for selecting and monitoring suitable study participants and the safety aspect during the trial. They apply their long-term clinical experience to the trial-specific parameters. In addition, they work closely with the respective responsible study coordinators in an effort to guarantee high-quality data.
Dr. med. Kerstin Sturm
Specialist for General Medicine
Study Coordinator / Medical Product Representative
Each coordinator and his work group is responsible for one trial or more. Work groups are responsible for transferring data from the source file to the case report form, ordering supplies and for organizing the cooperation with the monitor. They know even the smallest details concerning the study.
The study nurses are responsible for examining the trial patients. This includes sampling blood, spirometry, ECG and measurements of vital parameters, as well as conducting cognitive testing or reviewing diaries. Their scope of responsibility also includes trial drugs and archiving.